BILLS-117hr3537eh.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (14)
1965
5-year
later than 4 years
September 30, 2026
2026
2021
1ST SESSION H. R. 3537
1986
42 U.S.C. 284a
later than one year
December 8
later than 6 months
one year
days
EVENT (2)
the ‘‘Accelerating Access
SESSION
H. R. 3537
GPE (1)
the United States of America
NORP (1)
lish
ORG (37)
SEC
the Federal Food, Drug
Food, Drug
U.S.C.
Federal
Health and Human Services
the Food and Drug Administration
ALS
CONGRESS
the Public Health Service Act
the Food and Drug Adminis-
the Food and Drug
Senate
the House of Representatives
Labor
the Small Business Act
Food and Drug Administration
Health
the Comptroller General
Committee
non-Federal
Health, Education
HHS PUBLIC-PRIVATE PARTNERSHIP
House of Representa-
the Food and Drug Ad-
5
FUNDS.—A
the Commissioner of Food and Drugs
the Committee on Energy
the Department of
16
Health and Human Services
Human Services
the National Institutes of Health
Drug Administration
GAO
Health and Human
Services
APPROPRIATIONS
the Internal Revenue Code
Topic Classifications
congressional legislation
97.8%
government oversight
48.4%
public health
35.0%
Extracted Keywords
cure amyotrophic
amyotrophic lateral
amyotrophic
lateral sclerosis
sclerosis
lateral
investigational
expanded access
cure
clinical trials
trials
diagnosis
clinical
mitigation
drug
Forensic Analysis
PDF Metadata
- Creator
- ACOMP.exe WinVer 2.2a Sep 11 2014
- ModDate
- D:20221229133615Z
- Producer
- Acrobat Distiller 21.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20211208214222-05'00'
Sentiment
Polarity
Neutral
0.008
Subjectivity
44%
Objective